Toward medical countermeasures against hantaviruses
Cell Host & Microbe · 2026
DOI: 10.1016/j.chom.2026.08.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Host & Microbe, 2026. Verfasst von Martin Ferrié und 1 weiteren Autor:innen. Beteiligte Einrichtung: Virology, Antiviral Drug and Vaccine Research Group & VirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute …. Hauptthemen laut MEDLINE: Orthohantavirus, Hantavirus Infections, Antiviral Agents, Viral Vaccines. Die Arbeit nennt 15 Literaturangaben. Gefördert von: EU4Health, KU Leuven.
Abstract (Originalsprache)
Hantaviruses are zoonotic threats that can cause hemorrhagic fever with renal syndrome and severe cardiopulmonary syndrome. Despite disease severity, there are no approved vaccines or therapeutics available for the prevention or management of hantavirus infections. Here, we discuss advances in the development of vaccines, neutralizing antibodies, and small-molecule antiviral therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Virology, Antiviral Drug and Vaccine Research Group & VirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
- Virology, Antiviral Drug and Vaccine Research Group & VirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. Electronic address:…
Förderung
- EU4Health
- KU Leuven
Zitieren
APA
Ferrié, M., & Neyts, J. (2026). Toward medical countermeasures against hantaviruses. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2026.08.002
Vancouver
Ferrié M, Neyts J. Toward medical countermeasures against hantaviruses. Cell Host & Microbe. 2026. doi:10.1016/j.chom.2026.08.002
BibTeX
@article{Ferri2026,
author = {Ferrié, Martin and Neyts, Johan},
title = {Toward medical countermeasures against hantaviruses},
journal = {Cell Host & Microbe},
year = {2026},
doi = {10.1016/j.chom.2026.08.002}
}
EUVIMED